Rational design of a new series of mixed anti-HIV pronucleotides

Rational design of a new series of mixed anti-HIV pronucleotides Aryl nucleoside H-phosphonates. Part 16: Synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters Rational design of a new series of pronucleotide Phenyl phosphotriester derivatives of AZT: Variations upon the SATE moiety S-Acyl-2-thioethyl Aryl Phosphotriester Derivatives as Mononucleotide Prodrugs Mononucleoside Phosphotriester Derivatives with S-Acyl-2-thioethyl Bioreversible Phosphate-Protecting Groups: Intracellular Delivery of 3'-Azido-2',3'-dideoxythymidine 5'-Monophosphate S-Acyl-2-thioethyl Phosphoramidate Diester Derivatives as Mononucleotide Prodrugs S-Acyl-2-Thioethyl Aryl Phosphotriester Derivatives of AZT:  Synthesis, Antiviral Activity, and Stability Study Decomposition Pathways and in Vitro HIV Inhibitory Effects of IsoddA Pronucleotides:  Toward a Rational Approach for Intracellular Delivery of Nucleoside 5‘-Monophosphates Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT